Bone marrow transplantation prevents right ventricle disease in the caveolin-1-deficient mouse model of pulmonary hypertension.
暂无分享,去创建一个
S. Erzurum | B. Graham | K. Asosingh | B. Kassa | Liya Gebreab | Kimberly Queisser | N. Wanner | K. Weiss | Eric Stuehr | Kelly Weiss
[1] J. Cogan,et al. Bone Marrow-derived Cells Contribute to Pathogenesis of Pulmonary Arterial Hypertension. , 2015 .
[2] Hai Li,et al. Elafin Reverses Pulmonary Hypertension via Caveolin-1-Dependent Bone Morphogenetic Protein Signaling. , 2015, American journal of respiratory and critical care medicine.
[3] S. Archer,et al. The Right Ventricle in Pulmonary Arterial Hypertension: Disorders of Metabolism, Angiogenesis and Adrenergic Signaling in Right Ventricular Failure , 2014, Circulation research.
[4] Y. Cong,et al. Cav-1 deletion impaired hematopoietic stem cell function , 2014, Cell Death and Disease.
[5] S. Erzurum,et al. Nitrosation-Dependent Caveolin 1 Phosphorylation, Ubiquitination, and Degradation and its Association with Idiopathic Pulmonary Arterial Hypertension , 2013, Pulmonary circulation.
[6] M. Goodell,et al. Flow cytometry analysis of murine hematopoietic stem cells , 2013, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[7] P. Meikle,et al. Caveolin-1 Plays a Critical Role in the Differentiation of Monocytes into Macrophages , 2012, Arteriosclerosis, thrombosis, and vascular biology.
[8] S. Hazen,et al. Pulmonary vascular disease in mice xenografted with human BM progenitors from patients with pulmonary arterial hypertension. , 2012, Blood.
[9] Andres I Rodriguez,et al. Chronic hypoxia induces right heart failure in caveolin-1-/- mice. , 2012, American journal of physiology. Heart and circulatory physiology.
[10] W. Chung,et al. Whole Exome Sequencing to Identify a Novel Gene (Caveolin-1) Associated With Human Pulmonary Arterial Hypertension , 2012, Circulation. Cardiovascular genetics.
[11] M. Humbert,et al. Serotonin 5-HT2B receptors are required for bone-marrow contribution to pulmonary arterial hypertension. , 2012, Blood.
[12] S. Erzurum,et al. Pulmonary artery endothelium resident endothelial colony-forming cells in pulmonary arterial hypertension , 2011, Pulmonary circulation.
[13] A. Malik,et al. Persistent eNOS activation secondary to caveolin-1 deficiency induces pulmonary hypertension in mice and humans through PKG nitration. , 2009, The Journal of clinical investigation.
[14] L. Zon,et al. Hematopoiesis: An Evolving Paradigm for Stem Cell Biology , 2008, Cell.
[15] M. Rabinovitch. Molecular pathogenesis of pulmonary arterial hypertension. , 2008, The Journal of clinical investigation.
[16] W. Sessa,et al. Reexpression of caveolin-1 in endothelium rescues the vascular, cardiac, and pulmonary defects in global caveolin-1 knockout mice , 2007, The Journal of experimental medicine.
[17] M. Lisanti,et al. Short-Term Administration of a Cell-Permeable Caveolin-1 Peptide Prevents the Development of Monocrotaline-Induced Pulmonary Hypertension and Right Ventricular Hypertrophy , 2006, Circulation.
[18] F. Sotgia,et al. A Novel Role for Caveolin-1 in B Lymphocyte Function and the Development of Thymus-Independent Immune Responses , 2006, Cell cycle.
[19] D. Rodriguez,et al. Caveolin-1 controls cell proliferation and cell death by suppressing expression of the inhibitor of apoptosis protein survivin , 2006, Journal of Cell Science.
[20] N. Voelkel,et al. Loss of caveolin and heme oxygenase expression in severe pulmonary hypertension. , 2006, Chest.
[21] P. Sehgal,et al. Disruption of Endothelial-Cell Caveolin-1&agr;/Raft Scaffolding During Development of Monocrotaline-Induced Pulmonary Hypertension , 2004, Circulation.
[22] David S. Park,et al. Caveolin-1 null (-/-) mice show dramatic reductions in life span. , 2003, Biochemistry.
[23] E. Spisni,et al. Mechanosensing role of caveolae and caveolar constituents in human endothelial cells , 2003, Journal of cellular physiology.
[24] David S. Park,et al. Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts. , 2003, American journal of physiology. Cell physiology.
[25] G. Christ,et al. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. , 2001, The Journal of biological chemistry.
[26] M. Drab,et al. Loss of Caveolae, Vascular Dysfunction, and Pulmonary Defects in Caveolin-1 Gene-Disrupted Mice , 2001, Science.
[27] M. Lisanti,et al. Caveolin-1 expression negatively regulates cell cycle progression by inducing G(0)/G(1) arrest via a p53/p21(WAF1/Cip1)-dependent mechanism. , 2001, Molecular biology of the cell.
[28] M. Bitzer,et al. Caveolin-1 Regulates Transforming Growth Factor (TGF)-β/SMAD Signaling through an Interaction with the TGF-β Type I Receptor* , 2001, The Journal of Biological Chemistry.
[29] M. Lisanti,et al. Caveolins in cholesterol trafficking and signal transduction: implications for human disease. , 2000, Frontiers in bioscience : a journal and virtual library.
[30] M. Lisanti,et al. The Cyclin D1 Gene Is Transcriptionally Repressed by Caveolin-1* , 2000, The Journal of Biological Chemistry.
[31] R. G. Anderson. The caveolae membrane system. , 1998, Annual review of biochemistry.
[32] E. V. van Donselaar,et al. Cell-type and Tissue-specific Expression of Caveolin-2 , 1997, The Journal of Biological Chemistry.
[33] Richard G. W. Anderson,et al. A Role for Caveolin in Transport of Cholesterol from Endoplasmic Reticulum to Plasma Membrane* , 1996, The Journal of Biological Chemistry.
[34] M. Lisanti,et al. Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. , 1996, The Journal of biological chemistry.
[35] H. Lodish,et al. Identification, sequence, and expression of caveolin-2 defines a caveolin gene family. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[36] P. Dupree,et al. VIP21, a 21-kD membrane protein is an integral component of trans-Golgi- network-derived transport vesicles , 1992, The Journal of cell biology.
[37] Richard G. W. Anderson,et al. Caveolin, a protein component of caveolae membrane coats , 1992, Cell.
[38] R. G. Anderson,et al. Potocytosis: sequestration and transport of small molecules by caveolae. , 1992, Science.
[39] Fulton Rm,et al. VENTRICULAR WEIGHT IN CARDIAC HYPERTROPHY , 1952 .
[40] E. Hutchinson,et al. VENTRICULAR WEIGHT IN CARDIAC HYPERTROPHY , 1952, British heart journal.